WHO SOLIDARITY trial of re-purposed antiviral drugs for COVID-19: interim results

Participants were randomised to receive remdesivir, hydroxychloroquine, lopinavir, and interferon.
Participants were randomised to receive remdesivir, hydroxychloroquine, lopinavir, and interferon.